Hanesbrands Earnings Beat Estimates in Q4, Sales Increase Y/Y — Positive
HBI Zacks Investment Research — February 13, 2025HBI Q4 results reflect higher net sales and earnings. The gross margin expands 410 bps y/y on accelerated cost-saving initiatives and reduced input costs.

Shares of Datadog Inc (DDOG -9.49%) are trading lower on Thursday. The company's stock lost 8.4% as of noon ET but lost as much as 11.6% earlier in the day.

Snowflake Rises 22% Year to Date: Buy, Sell or Hold the Stock? — Positive
SNOW Zacks Investment Research — February 13, 2025SNOW is benefiting from strong AI partnerships, an expanding client base and strategic acquisitions amid intense competition and a stretched valuation.

AEIS Q4 Earnings & Revenues Beat, Stock Rises on Stable Outlook — Neutral
AEIS Zacks Investment Research — February 13, 2025Advanced Energy's fourth-quarter results highlight strong Data Center and Semiconductor demand despite headwinds in the Industrial, Medical and Telecom sectors.

Reddit Q4 Earnings & Revenues Top Estimates: Buy, Sell or Hold Stock? — Positive
RDDT Zacks Investment Research — February 13, 2025RDDT's fourth-quarter 2024 results benefit from strong top and bottom-line growth, rising user numbers, and international expansion.

Can MKSI's Solid Q4 Earnings and 1Q25 View Push the Stock Higher? — Positive
MKSI Zacks Investment Research — February 13, 2025MKS Instruments' fourth-quarter results reflect strength in the Semiconductor and Electronics & Packaging market amid sluggish Specialty Industrial demand.

Consumer goods manufacturing giant Unilever (UL -5.46%) reported mixed fourth-quarter and full-year 2024 earnings on Thursday, Feb. 13. Its underlying earnings per share (EPS) of 2.98 British pounds narrowly exceeded analyst consensus expectations of 2.965 pounds thanks to solid operational efficiency.

Options Trades: Bullish Strategies in NVDA and BA — Positive
NVDA Schwab Network — February 13, 2025Kevin Hincks provides example options trades for Nvidia (NVDA) and Boeing (BA). Nvidia reports earnings on February 26.

Pliant Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - PLRX — Neutral
PLRX Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pliant Therapeutics, Inc. ("Pliant Therapeutics, Inc.") (NASDAQ:PLRX) concerning possible violations of federal securities laws. On February 7, 2025, Pliant announced that following a prespecified data review and recommendations by the trial's independent Data Safety Monitoring Board, it had voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis.

Levi & Korsinsky Reminds Cardlytics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - CDLX — Neutral
CDLX Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=129355&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Edison Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - EIX — Neutral
EIX Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Edison International (NYSE:EIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edison-international-lawsuit-submission-form?prid=129356&wire=1 or contact Joseph E. Levi, Esq.

Evolus Announces FDA Approval of Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels — Neutral
EOLS Business Wire — February 13, 2025NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that the U.S. Food and Drug Administration (FDA) has approved Evolysse™ Form and Evolysse™ Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse™ collection. These approvals mark Evolus' entry into the U.S. HA dermal filler market and solidifies the company's position as a multi-product innovator in aesth.

CBRE Group, Inc. (CBRE) Q4 2024 Earnings Call Transcript — Neutral
CBRE Seeking Alpha — February 13, 2025CBRE Group, Inc. (NYSE:CBRE ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Chandni Luthra – Executive Vice President, Head of Investor Relations and FP&A Bob Sulentic – Chairman and Chief Executive Officer Emma Giamartino – Chief Financial Officer Conference Call Participants Anthony Paolone – JPMorgan Michael Griffin – Citi Julien Blouin – Goldman Sachs Ronald Kamdem – Morgan Stanley Stephen Sheldon – William Blair Steve Sakwa – Evercore ISI Alex Kramm – UBS Jade Rahmani – KBW Operator Greetings, and welcome to the Fourth Quarter 2024 CBRE Earnings Conference Call. At this time, all …

Adeia Enters into Multi-Year IP License Renewal with LG U+ — Neutral
ADEA GlobeNewsWire — February 13, 2025SAN JOSE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the technology company whose patented innovations enhance billions of devices and shape the way the world explores and experiences entertainment, today announced it has renewed its intellectual property (IP) license agreement with LG U+, one of South Korea's leading IPTV service providers. The multi-year license renewal extends LG U+'s access to Adeia's media portfolio for its products and services.

Galapagos NV (GLPG) Q4 2024 Earnings Call Transcript — Neutral
GLPG Seeking Alpha — February 13, 2025Galapagos NV (NASDAQ:GLPG ) Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ET Company Participants Sri Ramaswami - Senior Vice President and Global Head of Corporate Affairs & Investor Relations Paul Stoffels - Chair of the Board & Chief Executive Officer Thad Huston - Chief Financial Officer & Chief Operating Officer Valeria Cnossen - General Counsel Jeevan Shetty - Head of Clinical Development Oncology John Mellors - Head of Cell Therapy Discovery & Early Development Conference Call Participants Xian Deng - UBS Phil Nadeau - TD Cowen Brian Abrahams - RBC Capital Markets Faisal Khurshid - Leerink Partners …

Inspīr Embassy Row Celebrates Grand Opening, Ushering in New Era of Luxury Senior Living in Washington D.C. — Neutral
OHI PRNewsWire — February 13, 2025WASHINGTON , Feb. 13, 2025 /PRNewswire/ -- Maplewood Senior Living and Omega Healthcare Investors, Inc. (NYSE: OHI) celebrates the grand opening of Inspīr Embassy Row, Washington D.C.'s premier ultra-luxury senior living community, located in the historic Fairfax at Embassy Row building.

Pegasystems Inc. (PEGA) Q4 2024 Earnings Call Transcript — Neutral
PEGA Seeking Alpha — February 13, 2025Pegasystems Inc. (NASDAQ:PEGA ) Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ET Company Participants Peter Welburn - Vice President, Investor Relations Alan Trefler - Founder, Chief Executive Officer & of the Board Kenneth Stillwell - Chief Operating Officer & Chief Financial Officer Conference Call Participants Rishi Jaluria - RBC Steven Enders - Citi Pinjalim Bora - JPMorgan Jacob Roberge - William Blair Austin Cole - Citizens JMP Mark Schappel - Loop Capital Markets Devin Oh - KeyBanc Capital Markets Operator Ladies and gentlemen, thank you for standing by. My name is Krista and I will be your …

Royal Gold Q4 Earnings Top Estimates, Revenues Increase 33% Y/Y — Positive
RGLD Zacks Investment Research — February 13, 2025RGLD reports record 2024 revenues, backed by higher average metal prices and improved production at certain mines.

WAT Earnings & Sales Surpass Estimates in Q4, Shares Rise — Neutral
WAT Zacks Investment Research — February 13, 2025WAT's fourth-quarter 2024 results reflect strong pharma growth and robust gains across all regions. However, forex headwinds hurt.

Herc Holdings, Inc. (HRI) Q4 2024 Earnings Call Transcript — Neutral
HRI Seeking Alpha — February 13, 2025Herc Holdings, Inc. (NYSE:HRI ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Leslie Hunziker - SVP, IR, Communications & Sustainability Lawrence Silber - President, CEO & Director Aaron Birnbaum - SVP & COO Mark Humphrey - SVP & CFO Conference Call Participants Rob Wertheimer - Melius Research Tami Zakaria - JPMorgan Steven Ramsey - Thompson Research Group Neil Tyler - Redburn Atlantic Mig Dobre - Baird Kenneth Newman - KeyBanc Capital Markets Sherif El Sabbahy - Bank of America Merrill Lynch Brian Sponheimer - Gabelli Funds Operator Thank you for standing by. My name …
